energy metabolism

  1. Cort

    Article A Gut-Immune-Energy Model: Pt. II – The Armin Alaedini Interview

    This is the first Health Rising post to appear on PR. Fittingly, it's by Bronc - a PR member. Health Rising covered this fascinating gut/immune/metabolic study in an earlier blog. Now Bronc is back with an interview with Dr. Armin Alaedini – the senior author of this study. Note that we just...
  2. SWAlexander

    New study links 14 genes to ME/CFS

    A study has analysed existing genetic data in a new way to link 14 genes to ME/CFS and identify many patient subgroups. If the new approach pans out, it could transform ME research and turbocharge the development of treatments. Paper: Genetic Risk Factors for ME/CFS Identified Using...
  3. SNT Gatchaman

    FGF21 acts centrally to induce sympathetic nerve activity, energy expenditure, and weight loss (Owen et al, 2014)

    FGF21 acts centrally to induce sympathetic nerve activity, energy expenditure, and weight loss Bryn M. Owen, Xunshan Ding, Donald A. Morgan, Katie Colbert Coate, Angie L. Bookout, Kamal Rahmouni, Steven A. Kliewer, David J. Mangelsdorf The mechanism by which pharmacologic administration of the...
  4. SNT Gatchaman

    Going Back to the Biology of FGF21: New Insights (Lewis et al, 2019)

    Going Back to the Biology of FGF21: New Insights Jo E. Lewis, Francis J.P. Ebling, Ricardo J. Samms, Kostas Tsintzas Fibroblast growth factor 21 (FGF21) is a protein highly synthesized in the liver that exerts paracrine and endocrine control of many aspects of energy homeostasis in multiple...
  5. SNT Gatchaman

    Understanding the Physiology of FGF21 (Fisher and Maratos-Flier, 2015)

    Understanding the Physiology of FGF21 Ffolliott Martin Fisher and Eleftheria Maratos-Flier Fibroblast growth factor 21 (FGF21) is a peptide hormone that is synthesized by several organs and regulates energy homeostasis. Excitement surrounding this relatively recently identified hormone is based...
  6. leokitten

    Therapeutic efficacy of atypical antipsychotic drugs by targeting multiple stress-related metabolic pathways (Cai et al., Transl Psychiatry 2017)

    https://pubmed.ncbi.nlm.nih.gov/28509906/
  7. frozenborderline

    Paul Cheney Seminar--covers lots of research and clinical experience

    https://paradigmchange.me/wp/cheney/?fbclid=IwAR2kpq8tuZjP3mIeg9aZM2j6goro3ChWzK1LE_52m3nudQFVmmgn_cUnneY
Back